S100A4 and neoplasm: The combination of aPD1 treatment with the Vtnfl/fl S100a4‐Cre+ mice resulted in more pronounced reductions in tumor volume and weight than in the Vtnfl/fl S100a4‐Cre‐ group treated with aPD1 (Figure 7D‐F; Figure S9C, Supporting Information).